A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury*-Reference-Cited by-同舟云学术

A randomized trial of recombinant human granulocyte-macrophage colony stimulating factor for patients with acute lung injury*

Published:2012-01 Issue:1 Volume:40 Page:90-97
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Paine Robert,Standiford Theodore J.,Dechert Ronald E.,Moss Marc,Martin Gregory S.,Rosenberg Andrew L.,Thannickal Victor J.,Burnham Ellen L.,Brown Morton B.,Hyzy Robert C.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference4 articles.

1. The Acute Respiratory Distress Syndrome

2. Ventilation with Lower Tidal Volumes as Compared with Traditional Tidal Volumes for Acute Lung Injury and the Acute Respiratory Distress Syndrome

3. GM-CSF Regulates Pulmonary Surfactant Homeostasis and Alveolar Macrophage-Mediated Innate Host Defense

4. The effect of age on the development and outcome of adult sepsis*

Cited by 140 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Steroids and Immunomodulatory Therapies for Acute Respiratory Distress Syndrome;Clinics in Chest Medicine;2024-09

2. Barriers and Facilitators of Surrogates Providing Consent for Critically Ill Patients in Clinical Trials;CHEST;2024-08

3. An update on the pharmacological management of acute respiratory distress syndrome;Expert Opinion on Pharmacotherapy;2024-06-12

4. Adjunctive immunotherapeutic agents in patients with sepsis and septic shock: a multidisciplinary consensus of 23;Journal of Anesthesia, Analgesia and Critical Care;2024-04-30

5. Macrolides in Acute Respiratory Distress Syndrome and Acute Lung Injury;Progress in Inflammation Research;2024